Terms: = Ovarian cancer AND ATF1, TREB36, 466, ENSG00000123268, P18846 AND Treatment
16 results:
1. "More than a song and dance": Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok.
Morton M; Haight PJ; Khadraoui W; Backes F; Bixel K; O'Malley DM; Nagel C; Chambers LM
Gynecol Oncol; 2023 Aug; 175():81-87. PubMed ID: 37329872
[TBL] [Abstract] [Full Text] [Related]
2. A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib.
Guo M; Shu Y; Chen G; Li J; Li F
Sci Rep; 2022 Nov; 12(1):20601. PubMed ID: 36446798
[TBL] [Abstract] [Full Text] [Related]
3. Classification of High-Grade Serous ovarian cancer Using Tumor Morphologic Characteristics.
Handley KF; Sims TT; Bateman NW; Glassman D; Foster KI; Lee S; Yao J; Yao H; Fellman BM; Liu J; Lu Z; Conrads KA; Hood BL; Barakat W; Zhao L; Zhang J; Westin SN; Celestino J; Rangel KM; Badal S; Pereira I; Ram PT; Maxwell GL; Eberlin LS; Futreal PA; Bast RC; Fleming ND; Conrads TP; Sood AK
JAMA Netw Open; 2022 Oct; 5(10):e2236626. PubMed ID: 36239936
[TBL] [Abstract] [Full Text] [Related]
4. treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
Yoneoka Y; Ishikawa M; Uehara T; Shimizu H; Uno M; Murakami T; Kato T
J Gynecol Oncol; 2019 Sep; 30(5):e81. PubMed ID: 31328461
[TBL] [Abstract] [Full Text] [Related]
5. Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/atf1 signaling.
Xu Y; Zhou W; Zhang C; Liu X; Lv J; Li X; Zhao L; Li W; Li J; Ren Y; Ou R
Int J Biol Macromol; 2019 Jun; 130():24-33. PubMed ID: 30790638
[TBL] [Abstract] [Full Text] [Related]
6. Predictive Factors for Surgical Morbidities and Adjuvant Chemotherapy Delay for Advanced ovarian cancer Patients Treated by Primary Debulking Surgery or Interval Debulking Surgery.
Castro BGR; Dos Reis R; Cintra GF; Sousa MMA; Vieira MA; Andrade CEMDC
Int J Gynecol Cancer; 2018 Oct; 28(8):1520-1528. PubMed ID: 30036229
[TBL] [Abstract] [Full Text] [Related]
7. Adequate pelvic lymphadenectomy and survival of women with early-stage epithelial ovarian cancer.
Matsuo K; Machida H; Mariani A; Mandelbaum RS; Glaser GE; Gostout BS; Roman LD; Wright JD
J Gynecol Oncol; 2018 Sep; 29(5):e69. PubMed ID: 30022633
[TBL] [Abstract] [Full Text] [Related]
8. ovarian masses in infant-juvenile age.
Sonmez K; Turkyilmaz Z; Karabulut R; Can Basaklar A
Arch Argent Pediatr; 2018 Jun; 116(3):e359-e364. PubMed ID: 29756706
[TBL] [Abstract] [Full Text] [Related]
9. Breast cancer Risk After Radiation Therapy for Hodgkin Lymphoma: Influence of Gonadal Hormone Exposure.
Krul IM; Opstal-van Winden AWJ; Aleman BMP; Janus CPM; van Eggermond AM; De Bruin ML; Hauptmann M; Krol ADG; Schaapveld M; Broeks A; Kooijman KR; Fase S; Lybeert ML; Zijlstra JM; van der Maazen RWM; Kesminiene A; Diallo I; de Vathaire F; Russell NS; van Leeuwen FE
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):843-853. PubMed ID: 28888722
[TBL] [Abstract] [Full Text] [Related]
10. A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells.
Balch C; Naegeli K; Nam S; Ballard B; Hyslop A; Melki C; Reilly E; Hur MW; Nephew KP
Cancer Biol Ther; 2012 Jun; 13(8):681-93. PubMed ID: 22549158
[TBL] [Abstract] [Full Text] [Related]
11. [Endometrioid endometrial cancer--the prognostic value of selected clinical and pathological parameters].
Gottwald L; Chałubińska J; Moszyńska-Zielińska M; Piekarski J; Tyliński W; Szwalski J; Kubiak R; Pasz-Walczak G; Hendzel K; Ciałkowska-Rysz A
Ginekol Pol; 2011 Oct; 82(10):743-8. PubMed ID: 22379937
[TBL] [Abstract] [Full Text] [Related]
12. Elevated plasma growth differentiation factor-15 correlates with lymph node metastases and poor survival in endometrial cancer.
Staff AC; Trovik J; Eriksson AG; Wik E; Wollert KC; Kempf T; Salvesen HB
Clin Cancer Res; 2011 Jul; 17(14):4825-33. PubMed ID: 21616994
[TBL] [Abstract] [Full Text] [Related]
13. Decreased hypersensitivity reactions with carboplatin-pegylated liposomal doxorubicin compared to carboplatin-paclitaxel combination: analysis from the GCIG CALYPSO relapsing ovarian cancer trial.
Joly F; Ray-Coquard I; Fabbro M; Donoghoe M; Boman K; Sugimoto A; Vaughan M; Reinthaller A; Vergote I; Ferrandina G; Dell'Anna T; Huober J; Pujade-Lauraine E
Gynecol Oncol; 2011 Aug; 122(2):226-32. PubMed ID: 21575983
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical features and treatment of choroidal metastasis].
Wang GL; Wang MY; Wei WB
Zhonghua Yan Ke Za Zhi; 2009 Mar; 45(3):229-33. PubMed ID: 19575917
[TBL] [Abstract] [Full Text] [Related]
15. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.
Materna V; Pleger J; Hoffmann U; Lage H
Gynecol Oncol; 2004 Jul; 94(1):152-60. PubMed ID: 15262134
[TBL] [Abstract] [Full Text] [Related]
16. [Carcinoembryonic antigen (C.E.A.). Its value in the care of malignant tumours of the ovary (author's transl)].
Laffargue F; Thomas M; Piana L; Gibert-Blondeau D; Bougrand P; Serment H
J Gynecol Obstet Biol Reprod (Paris); 1981; 10(5):435-42. PubMed ID: 7320442
[TBL] [Abstract] [Full Text] [Related]
